Cancer

A Stanford Medicine study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don’t meet current screening guidelines.

Treatment of metastatic disease is responsible for nearly one-third of the decrease in annual deaths from breast cancer from 1975 to 2019, according to a Stanford Medicine-led study.

Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.

Pancreatic cancer is deadly, and its toll is growing. Scientists find that scar tissue around the tumor suggests how long a patient will live after diagnosis.

To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.

In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.

After years of practicing surgery techniques in a part of the brain known as a “no man’s land,” Juan Fernandez-Miranda was able to remove a complex pituitary gland tumor from a Lebanese teenager.

Stanford Health Care – ValleyCare physician performs surgery on a cancer patient with the help of a da Vinci robotic system. The technology eases patients’ recovery and offers surgeons a clear view of the procedure.

CAR-T cell therapy works for many types of blood cancers, but more than half of patients relapse. A Stanford study provides a clue as to why.

The team, composed of researchers at nine academic institutions, has published more than 100 papers and treated nearly 1,000 children with cancer in early-phase clinical trials.

Analyzing a national cancer database, researchers find a bump in diagnoses at 65, suggesting that many wait for Medicare to kick in before they seek care.